Menu
Recruiting NCT06883357

The Effects of Home-based Graded Repetitive Arm Supplementary Program Group on Stroke.

No phase Interventional Stroke

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Graded repetitive arm supplementary program (GRASP).
Who it may be relevant to
Registry conditions: Stroke. Basic parameters: from 20 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Taiwan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

The Effects of Home-based Graded Repetitive Arm Supplementary Program Group on Stroke: the Randomized Controlled Trial.

Overview

Graded repetitive arm supplementary program (GRASP) is a self administrated, home-based rehabilitation program and has been incorporated in Canadian Stroke Best Practice Recommendations. Past studies indicated that the home-based GRASP program could facilitate the motor function and motor recovery and prevent learned nonuse of affected upper limb of stroke patients. There is lacking of research and application of the home-based GRASP program in Taiwan. Therefore, this study aims to explore the effects of the home-based GRASP program, which is mainly executed in the form of group intervention, on the affected upper limb of stroke patients.

Interventions

  • Behavioral Graded repetitive arm supplementary program (GRASP)
    Graded repetitive arm supplementary program (GRASP) is a self administrated, home-based rehabilitation program. home-based GRASP program could facilitate the motor function and motor recovery and prevent learned nonuse of affected upper limb of stroke patients. Participants in experimental group will receive Home GRASP program which will be executed 1hour at home per day. In addition, Participants will be requested to return hospital for follow-up and adjusting the training program in group disc

Primary outcome measures

  • Fugl-Meyer Assessment for upper extremity (FMA-UE) [Time frame: From enrollment to the end of treatment at 6 weeks]
  • Jamar Hydraulic Hand Dynamometer (Jamar Dynamometer) [Time frame: From enrollment to the end of treatment at 6 weeks]
  • Action Research Arm Test (ARAT) [Time frame: From enrollment to the end of treatment at 6 weeks]
Secondary outcome measures (3)
  • Chedoke Arm and Hand Activity Inventory (CAHAI) [Time frame: From enrollment to the end of treatment at 6 weeks]
  • Rating of Everyday Arm-use in the Community and Home Scale (REACH-Scale) [Time frame: From enrollment to the end of treatment at 6 weeks]
  • Stroke Impact Scale Version 3.0 (SIS 3.0) [Time frame: From enrollment to the end of treatment at 6 weeks]

Eligibility criteria

Inclusion criteria

  • Age is above 20 years old.
  • Onset of first stroke complicated with hemiplegia or hemiparesis.
  • The affected upper limb remains partially voluntary movements including lifting to chest level and holding for five seconds; slight flexion and extension of wrist and hand.
  • Understanding and complying with two-steps commands.
  • Understanding the content of trial and willing to sign informed consent.

Exclusion criteria

  • Complicating with other neurological disease.
  • Having Orthopedic diseases affecting the movements of upper limbs.
  • Having symptoms of pain to affect the movements of upper limbs.
  • Unstable vital sign or medical condition.
  • Participating another rehabilitative or drug research meanwhile.
  • Receiving botulinum toxin injection within three months.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Taiwan · 1 center
  • National Taiwan University Hospital Hsin-Chu Branch — Hsinchu

Identifiers

NCT: NCT06883357 · 202407010RINB

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗